Cleveland BioLabs Price to Sales Ratio 2006-2018 | CBLI

Historical PS ratio values for Cleveland BioLabs (CBLI) over the last 10 years. The current P/S ratio for Cleveland BioLabs as of April 25, 2019 is .
Cleveland BioLabs P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-04-25 1.45 14.39
2018-12-31 1.01 $0.10 10.02
2018-09-30 2.01 $0.16 12.75
2018-06-30 2.46 $0.16 15.48
2018-03-31 3.07 $0.14 21.52
2017-12-31 4.01 $0.17 22.94
2017-09-30 3.44 $0.19 18.38
2017-06-30 2.95 $0.26 11.15
2017-03-31 1.60 $0.30 5.36
2016-12-31 1.42 $0.32 4.43
2016-09-30 1.65 $0.41 4.02
2016-06-30 2.98 $0.36 8.38
2016-03-31 2.53 $0.39 6.55
2015-12-31 3.49 $0.50 6.96
2015-09-30 4.34 $0.84 5.19
2015-06-30 4.34 $0.93 4.66
2015-03-31 3.56 $1.07 3.34
2014-12-31 5.70 $1.41 4.04
2014-09-30 9.18 $2.62 3.51
2014-06-30 9.61 $3.20 3.01
2014-03-31 13.62 $3.70 3.68
2013-12-31 23.40 $3.77 6.20
2013-09-30 31.40 $3.21 9.78
2013-06-30 31.60 $2.61 12.12
2013-03-31 39.20 $2.03 19.28
2012-12-31 26.60 $1.95 13.67
2012-09-30 53.60 $1.98 27.01
2012-06-30 31.40 $4.01 7.84
2012-03-31 49.20 $4.17 11.81
2011-12-31 57.20 $5.34 10.71
2011-09-30 50.60 $7.02 7.21
2011-06-30 68.20 $7.24 9.42
2011-03-31 150.00 $10.09 14.87
2010-12-31 144.40 $11.93 12.10
2010-09-30 103.20 $14.70 7.02
2010-06-30 73.20 $16.40 4.46
2010-03-31 71.20 $18.91 3.77
2009-12-31 66.20 $18.76 3.53
2009-09-30 83.40 $15.34 5.44
2009-06-30 86.20 $14.00 6.16
2009-03-31 51.20 $9.34 5.48
2008-12-31 42.60 $6.98 6.10
2008-09-30 86.20 $5.41 15.92
2008-06-30 91.00 $3.78 24.08
2008-03-31 81.40 $3.84 21.22
2007-12-31 176.00 $3.35 52.54
2007-09-30 230.60 $3.21 71.91
2007-06-30 219.20 $2.73 80.44
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.016B $0.001B
CLEVELAND BIOLABS, INC. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Radiobiology Research Institute. The Company's proprietary technology platform is based on the ability to suppress or stimulate programmed cell death (apoptosis). CBLI's drugs can switch apoptosis on and off by affecting key regulators of cell response to stresses, such as radiation or ischemia. CBLI is pursuing three key areas of research: Biodefense for Acute Radiation Syndrome, Cancer Treatment, and Tissue Protection.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $111.167B 12.52
Gilead Sciences (GILD) United States $81.772B 10.41
Celgene (CELG) United States $65.974B 11.22
Illumina (ILMN) United States $46.893B 54.38
Vertex Pharmaceuticals (VRTX) United States $44.640B 59.80
Biogen (BIIB) United States $44.574B 8.46
Regeneron Pharmaceuticals (REGN) United States $38.246B 17.77
Alexion Pharmaceuticals (ALXN) United States $30.320B 17.22
Incyte (INCY) United States $15.843B 147.88
BioMarin Pharmaceutical (BMRN) United States $15.217B 0.00
Exact Sciences (EXAS) United States $11.996B 0.00
Seattle Genetics (SGEN) United States $11.442B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.342B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
QIAGEN (QGEN) Netherlands $8.723B 28.87
Sarepta Therapeutics (SRPT) United States $8.571B 0.00
Moderna (MRNA) United States $8.468B 0.00
Bluebird Bio (BLUE) United States $7.656B 0.00
Bio-Techne Corp (TECH) United States $7.224B 48.67
BeiGene (BGNE) Cayman Islands $7.215B 0.00
Amarin (AMRN) Ireland $6.174B 0.00
Exelixis (EXEL) United States $6.027B 13.99
Galapagos (GLPG) Belgium $5.782B 0.00
Guardant Health (GH) United States $5.618B 0.00
Array BioPharma (ARRY) United States $4.945B 0.00
Alkermes (ALKS) Ireland $4.755B 0.00
Ascendis Pharma (ASND) Denmark $4.695B 0.00
Horizon Pharma Public (HZNP) Ireland $4.666B 13.82
Spark Therapeutics (ONCE) United States $4.228B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.935B 0.00
China Biologic Products (CBPO) China $3.931B 24.36
ARGENX SE-ADR (ARGX) Netherlands $3.874B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.518B 0.00
Allogene Therapeutics (ALLO) United States $3.394B 0.00
Blueprint Medicines (BPMC) United States $3.391B 0.00
Global Blood Therapeutics (GBT) United States $3.181B 0.00
Immunomedics (IMMU) United States $3.173B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.060B 0.00
Amicus Therapeutics (FOLD) United States $3.056B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.850B 0.00
Emergent Biosolutions (EBS) United States $2.767B 23.02
Intercept Pharmaceuticals (ICPT) United States $2.640B 0.00
Repligen (RGEN) United States $2.523B 77.35
Genomic Health (GHDX) United States $2.453B 62.70
Akcea Therapeutics (AKCA) United States $2.449B 0.00
Ligand Pharmaceuticals (LGND) United States $2.444B 18.97
Halozyme Therapeutics (HALO) United States $2.355B 0.00
Insmed (INSM) United States $2.347B 0.00
Reata Pharmaceuticals (RETA) United States $2.334B 0.00
Denali Therapeutics (DNLI) United States $2.316B 0.00
Myriad Genetics (MYGN) United States $2.315B 23.58
Arena Pharmaceuticals (ARNA) United States $2.307B 0.00
Mirati Therapeutics (MRTX) United States $2.303B 0.00
MyoKardia (MYOK) United States $2.257B 0.00
Medicines (MDCO) United States $2.201B 0.00
Acceleron Pharma (XLRN) United States $2.168B 0.00
UniQure (QURE) Netherlands $2.124B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.068B 0.00
AnaptysBio (ANAB) United States $2.006B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.952B 0.00
REGENXBIO (RGNX) United States $1.931B 20.06
NeoGenomics (NEO) United States $1.931B 155.85
Audentes Therapeutics (BOLD) United States $1.718B 0.00
Allakos (ALLK) United States $1.674B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.651B 0.00
Atara Biotherapeutics (ATRA) United States $1.542B 0.00
Alector (ALEC) United States $1.479B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.454B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.435B 0.00
Innoviva (INVA) United States $1.374B 3.79
Cambrex (CBM) United States $1.368B 14.73
Rubius Therapeutics (RUBY) United States $1.364B 0.00
Lion Biotechnologies (IOVA) United States $1.361B 0.00
Editas Medicine (EDIT) United States $1.333B 0.00
Aimmune Therapeutics (AIMT) United States $1.318B 0.00
Puma Biotechnology (PBYI) United States $1.294B 0.00
InflaRx (IFRX) Germany $1.285B 0.00
Myovant Sciences (MYOV) United Kingdom $1.284B 0.00
Apellis Pharmaceuticals (APLS) United States $1.217B 0.00
Sangamo Therapeutics (SGMO) United States $1.212B 0.00
Epizyme (EPZM) United States $1.142B 0.00
Fate Therapeutics (FATE) United States $1.137B 0.00
Gossamer Bio (GOSS) United States $1.068B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.055B 0.00
Codexis (CDXS) United States $1.040B 0.00
Coherus BioSciences (CHRS) United States $1.037B 0.00
Clovis Oncology (CLVS) United States $1.012B 0.00
NGM BIOPHARMACT (NGM) United States $1.012B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.959B 0.00
RA PHARMCTL INC (RARX) United States $0.958B 0.00
WAVE Life Sciences (WVE) Singapore $0.948B 0.00
Genfit SA (GNFT) France $0.947B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.935B 0.00
Twist Bioscience (TWST) United States $0.927B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.926B 0.00
Eidos Therapeutics (EIDX) United States $0.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.917B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.877B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.875B 35.36
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.865B 0.00
ANI Pharmaceuticals (ANIP) United States $0.826B 15.11
Cellectis (CLLS) France $0.813B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.805B 0.00
Retrophin (RTRX) United States $0.803B 0.00
Vericel (VCEL) United States $0.771B 0.00
Cara Therapeutics (CARA) United States $0.771B 0.00
Intellia Therapeutics (NTLA) United States $0.764B 0.00
Intra-Cellular Therapies (ITCI) United States $0.742B 0.00
Arvinas (ARVN) United States $0.732B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.719B 0.00
Athenex (ATNX) United States $0.708B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.701B 0.00
G1 THERAPEUTICS (GTHX) United States $0.678B 0.00
Principia Biopharma (PRNB) United States $0.670B 0.00
Stemline Therapeutics (STML) United States $0.621B 0.00
Zealand Pharma (ZEAL) Denmark $0.619B 6.88
ObsEva SA (OBSV) Switzerland $0.614B 0.00
MeiraGTx Holdings (MGTX) United States $0.614B 0.00
Precision BioSciences (DTIL) United States $0.613B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.603B 0.00
Viking Therapeutics (VKTX) United States $0.601B 0.00
Heska (HSKA) United States $0.596B 53.49
Revance Therapeutics (RVNC) United States $0.589B 0.00
DBV Technologies (DBVT) France $0.568B 0.00
Kura Oncology (KURA) United States $0.561B 0.00
Axsome Therapeutics (AXSM) United States $0.556B 0.00
Magenta Therapeutics (MGTA) United States $0.545B 0.00
Zymeworks (ZYME) Canada $0.544B 0.00
Acorda Therapeutics (ACOR) United States $0.533B 6.90
Synthorx (THOR) United States $0.521B 0.00
Mesoblast (MESO) Australia $0.519B 0.00
Replimune (REPL) United States $0.517B 0.00
Cytokineticsorporated (CYTK) United States $0.512B 0.00
UROGEN PHARMA (URGN) United States $0.510B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.488B 0.00
Scholar Rock Holding (SRRK) United States $0.484B 0.00
AVROBIO (AVRO) United States $0.480B 0.00
Arcus Biosciences (RCUS) United States $0.476B 0.00
Krystal Biotech (KRYS) United States $0.474B 0.00
MediciNova (MNOV) United States $0.468B 0.00
Anika Therapeutics (ANIK) United States $0.464B 17.54
CytomX Therapeutics (CTMX) United States $0.446B 0.00
Sorrento Therapeutics (SRNE) United States $0.444B 0.00
KALEIDO BIOSCI (KLDO) $0.443B 0.00
Senesco Technologies (ELOX) United States $0.437B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.436B 0.00
PDL BioPharma (PDLI) United States $0.433B 9.66
Prothena (PRTA) Ireland $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.431B 0.00
Five Prime Therapeutics (FPRX) United States $0.431B 0.00
Dynavax Technologies (DVAX) United States $0.427B 0.00
CYCLERION THERA (CYCN) United States $0.423B 0.00
Adverum Biotechnologies (ADVM) United States $0.420B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.412B 0.00
STEALTH BIOTHER (MITO) United States $0.409B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.398B 0.00
Albireo Pharma (ALBO) United States $0.383B 0.00
Inovio Pharmaceuticals (INO) United States $0.375B 0.00
Kezar Life Sciences (KZR) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Kindred Biosciences (KIN) United States $0.363B 0.00
Geron (GERN) United States $0.351B 0.00
Agenus (AGEN) United States $0.349B 0.00
BioDelivery Sciences (BDSI) United States $0.343B 0.00
XBiotech (XBIT) United States $0.342B 0.00
UNITY Biotechnology (UBX) $0.339B 0.00
PHASEBIO PHARMA (PHAS) United States $0.335B 0.00
Solid Biosciences (SLDB) United States $0.335B 0.00
AC Immune SA (ACIU) Switzerland $0.326B 0.00
BeyondSpring (BYSI) United States $0.319B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.313B 0.00
Constellation Pharmaceuticals (CNST) United States $0.312B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
MannKind (MNKD) United States $0.300B 0.00
LogicBio Therapeutics (LOGC) United States $0.300B 0.00
Kadmon Holdings (KDMN) United States $0.286B 0.00
Seres Therapeutics (MCRB) United States $0.284B 0.00
Aduro Biotech (ADRO) United States $0.283B 0.00
Kodiak Sciences (KOD) United States $0.271B 0.00
Evelo Biosciences (EVLO) United States $0.271B 0.00
ResTORbio (TORC) United States $0.266B 0.00
Strongbridge Biopharma (SBBP) United States $0.257B 0.00
Avid Bioservices (CDMO) United States $0.256B 0.00
Kala Pharmaceuticals (KALA) United States $0.255B 0.00
Enochian BioSciences (ENOB) United States $0.255B 0.00
Urovant Sciences (UROV) United States $0.253B 0.00
ChromaDex (CDXC) United States $0.253B 0.00
Arsanis (XFOR) United States $0.250B 0.00
Kamada (KMDA) Israel $0.247B 11.15
Xenon Pharmaceuticals (XENE) Canada $0.242B 0.00
Cerecor (CERC) United States $0.239B 0.00
Novavax (NVAX) United States $0.237B 0.00
Athersys (ATHX) United States $0.235B 0.00
Sutro Biopharma (STRO) United States $0.234B 0.00
Protagonist Therapeutics (PTGX) United States $0.233B 0.00
Cel-Sci (CVM) United States $0.230B 0.00
Palatin Technologies (PTN) United States $0.227B 112.00
Syros Pharmaceuticals (SYRS) United States $0.227B 0.00
OSMOTICA PHARM (OSMT) United States $0.221B 0.00
Celcuity (CELC) United States $0.220B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.217B 0.00
ADMA Biologics Inc (ADMA) United States $0.216B 0.00
OvaScience (MLND) United States $0.214B 0.00
TOCAGEN INC (TOCA) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Gamida Cell (GMDA) Israel $0.205B 0.00
Intec Pharma (NTEC) Israel $0.200B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
Axovant Sciences (AXGT) United Kingdom $0.197B 0.00
CorMedix Inc (CRMD) United States $0.191B 0.00
VBI Vaccines (VBIV) United States $0.190B 0.00
Synlogic (SYBX) United States $0.189B 0.00
BioTime (BTX) United States $0.184B 0.00
Pfenex (PFNX) United States $0.184B 0.00
Compugen (CGEN) Israel $0.178B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.175B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.168B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Enzo Biochem (ENZ) United States $0.165B 0.00
BioXcel Therapeutics (BTAI) United States $0.163B 0.00
Verastem (VSTM) United States $0.160B 0.00
Chiasma (CHMA) United States $0.149B 0.00
Mustang Bio (MBIO) United States $0.147B 0.00
Arbutus Biopharma (ABUS) Canada $0.147B 0.00
Liquidia Technologies (LQDA) United States $0.145B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.145B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.145B 0.00
Anavex Life Sciences (AVXL) United States $0.140B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.139B 0.00
Neothetics (EVFM) United States $0.138B 0.00
Trevena (TRVN) United States $0.136B 0.00
Allena Pharmaceuticals (ALNA) United States $0.134B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.129B 0.00
VolitionRX (VNRX) Singapore $0.129B 0.00
Provention Bio (PRVB) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.127B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.127B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.122B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.119B 0.00
Organovo Holdings (ONVO) United States $0.118B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.108B 0.00
Unum Therapeutics (UMRX) United States $0.106B 0.00
XOMA (XOMA) United States $0.105B 0.00
INMUNE BIO INC (INMB) United States $0.103B 0.00
Cohbar (CWBR) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
Fortress Biotech (FBIO) United States $0.098B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.095B 0.00
Selecta Biosciences (SELB) United States $0.094B 0.00
Equillium (EQ) United States $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.090B 0.00
NantKwest (NK) United States $0.089B 0.00
Signal Genetics (MGEN) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.084B 89.00
SESEN BIO, INC (SESN) United States $0.084B 0.00
Applied Genetic Technologies (AGTC) United States $0.084B 0.00
Alcobra (ARCT) United States $0.084B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.082B 0.00
Aptose Biosciences (APTO) Canada $0.081B 0.00
Eyenovia (EYEN) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.076B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.067B 0.00
Zosano Pharma (ZSAN) United States $0.066B 0.00
AEterna Zentaris (AEZS) United States $0.064B 15.60
Cidara Therapeutics (CDTX) United States $0.064B 0.00
ARAVIVE, INC (ARAV) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.061B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Apricus Biosciences (SEEL) United States $0.061B 0.00
Curis (CRIS) United States $0.059B 0.00
Ophthotech (ISEE) United States $0.058B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.058B 0.00
Evogene (EVGN) Israel $0.057B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
Moleculin Biotech (MBRX) United States $0.050B 0.00
HOTH THERAPEUTC (HOTH) United States $0.050B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
AZURRX BIOPHARM (AZRX) United States $0.046B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.046B 0.00
Celldex Therapeutics (CLDX) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
ANCHIANO THERAP (ANCN) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.042B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
VIVUS (VVUS) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Motif Bio Plc (MTFB) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Sophiris Bio (SPHS) United States $0.028B 0.00
GTx (GTXI) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.024B 0.00
Fibrocell Science Inc (FCSC) United States $0.024B 0.00
ATyr Pharma (LIFE) United States $0.023B 0.00
Oragenics (OGEN) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
IMMURON LTD (IMRN) Australia $0.020B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
CytRx (CYTR) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Histogenics (HSGX) United States $0.017B 0.00
Vital Therapies (IMUX) United States $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Oncobiologics (OTLK) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.96
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Edge Therapeutics (PDSB) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.002B 0.00